









Markets
/
Stocks
/
nasdaq-sdgr
/

Schrodinger Inc

SDGR

19.430USD

+0.400+2.10%

Market hours （ET）Quotes delayed by 15 min

1.43BMarket Cap

LossP/E TTM



Schrodinger Inc

19.430

+0.400+2.10%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

129 / 470

Overall Ranking

206 / 4723

Industry

Software & IT Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 9 analysts

Buy

Current Rating

28.111

Target Price

+47.10%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The Company operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 25.43.

Turnaround to Loss

The company's performance has turned to a loss, with the latest annual loss of USD 187.12M.%!(EXTRA int=2)

Fairly Valued

The company’s latest PE is -7.67, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 66.46M shares, decreasing 7.77% quarter-over-quarter.

Held by Bill Gates

Star Investor Bill Gates holds 6.98M shares of this stock.

Financial Health

Currency: USD Updated：2025-09-17

The company's current financial score is 6.03, which is lower than the Software & IT Services industry's average of 7.27. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 54.76M, representing a year-over-year increase of 15.69%, while its net profit experienced a year-over-year increase of 20.12%.

Score

Industry at a Glance

Previous score

6.03

Change



Financials

9.25

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.95

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

3.07

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

2.82

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.08

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 1.20, which is lower than the Software & IT Services industry's average of 2.10. Its current P/E ratio is -7.67, which is -589.21% below the recent high of 37.53 and -16.96% above the recent low of -8.97.

Score

Industry at a Glance

Previous score

1.20

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 129/470

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

The company’s current earnings forecast score is 8.00, which is higher than the Software & IT Services industry's average of 7.60. The average price target for Schrodinger Inc is 30.00, with a high of 33.00 and a low of 19.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 9 analysts

Buy

Current Rating

28.111

Target Price

+47.72%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

242

Total

Median

Average

Company name

Ratings

Analysts

Schrodinger Inc

SDGR

Microsoft Corp

MSFT

Palo Alto Networks Inc

PANW

Zscaler Inc

ServiceNow Inc

NOW

Fortinet Inc

FTNT

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 6.54, which is lower than the Software & IT Services industry's average of 7.42. Sideways: Currently, the stock price is trading between the resistance level at 20.27 and the support level at 17.96, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.57

Change

-0.03

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.047

Neutral

RSI(14)

46.470

Neutral

STOCH(KDJ)(9,3,3)

48.094

Buy

ATR(14)

0.690

High Vlolatility

CCI(14)

35.797

Neutral

Williams %R

53.125

Neutral

TRIX(12,20)

-0.261

Sell

StochRSI(14)

89.705

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

18.790

Buy

MA10

18.910

Buy

MA20

19.250

Buy

MA50

20.117

Sell

MA100

21.442

Sell

MA200

21.781

Sell

Institutional Confidence

Currency: USD Updated：2025-09-17

The company’s current institutional recognition score is 10.00, which is higher than the Software & IT Services industry's average of 6.81. The latest institutional shareholding proportion is 103.14%, representing a quarter-over-quarter decrease of 1.49%. The largest institutional shareholder is Bill Gates, holding a total of 6.98M shares, representing 10.83% of shares outstanding, with 1.13% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

7.75M

-4.37%

Bill & Melinda Gates Foundation Trust

Star Investors

6.98M

The Vanguard Group, Inc.

Star Investors

6.53M

-1.09%

Rubric Capital Management LP

4.80M

-4.00%

Amova Asset Management Co., Ltd.

3.46M

-1.37%

Cadian Capital Management LP

1.10M

Stephens Investment Management Group, LLC

1.97M

+22.53%

State Street Global Advisors (US)

2.21M

-4.52%

ARK Investment Management LLC

Star Investors

2.29M

+3.88%

UBS Asset Management (Americas) LLC

1.81M

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 5.09, which is higher than the Software & IT Services industry's average of 4.01. The company's beta value is 1.74. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.